The potential role of vitamin D in the prevention and treatment of colorectal cancer (CRC) attracted the growing research interest – especially with the growing CRC indicators, especially among among among the among among among among, among Younger adults. This is not a modern area of study. The low level of vitamin D has long been associated with a higher risk of developing colorectal cancer.
One large study The involvement of over 12,000 participants said that people with low levels of vitamin D in the blood had a 31% higher risk of developing CRC compared to people with higher levels. Similarly, Next examination He reported a 25% lower risk of CRC among people with high vitamin D intake in the diet.
Data From the health research of nurses-a long-term study of American nurses-showed that women with the highest intake of vitamin D had a 58% lower risk of developing colorectal cancer compared to people with the lowest consumption.
Now, review It emphasizes the promise of vitamin D in preventing colorectal cancer and treatment – but also emphasizes the complexity and contradictions in current studies.
One sec Observation datawhich occurs after the employ of vitamin D by people and Mechanical researchTo examine how vitamin D works in a laboratory, it suggests protective effects, this is not confirmed by greater research.
In fact, randomized controlled research (RCT), in which some people receive vitamin D, and others do not, the golden standard, according to which treatments are assessed, reveal inconsistent results. This emphasizes the need for a sustainable approach to integration with public health strategies.
Vitamin D is synthesized in the skin in Response to sunlight and has its biological effects Vitamin D receptors (VDRS) Found throughout the body, including in the colon tissue. After activation, these receptors aid regulate the activity of genes related to inflammation, Immune response and cell growth – key processes for the development and progress of cancer.
Pre -clinical tests have shown that the dynamic form of vitamin D (calcitriol) can suppress inflammation, improve immune supervision (the ability of the immune system to detect abnormal cells), inhibit the growth of blood vessels and regulate the division of cells – key factor in the development of cancer, as shown in my last tests.
Epidemiological researchwhich follow health results in vast populations in time, consistently state that people with higher levels of vitamin D in their blood have lower risk CRC development. It paints a hopeful picture, which suggests that something as elementary as getting more vitamin D – through exposure to the sun, diet or supplements – can reduce the risk of cancer.
But history becomes more complicated.
Mixed results
When it comes to making medical decisions, randomized controlled research (RCT) is a golden standard. These research randomly grant participants to receive treatment (such as vitamin D) or placebo, helping to eliminate bias and isolate cause-effect compounds.
Unfortunately, RCT on vitamins D and CRC brought mixed results.
For example Important study – Main RCT with the participation of over 25,000 participants – there was no significant reduction in the overall frequency of colorectal cancer from 2000 IU/Vitamin D supplementation day for several years.
However, the meta -analysis of the seven RCT showed 30% improvement of CRC survival Indicators with vitamin D supplements, which suggests potential benefits at a later time, not prevention.
On the other hand D/calcium vitamin prevention test There was no reduction in the recurrence of adenoma (precancerous growth) with supplementation, asking questions about who uses the majority and what dose.
Adding uncertainty is Question about the cause. Does low vitamin D contribute to cancer development? Does the beginning of cancer reduce the level of vitamin D in the body? It is also possible that the observed benefits are partly caused Increased exposure to sunlightwhich can have independent protective effects.
Great picture
These discrepancies emphasize the importance of consideration “Totality of evidence” – treating each study as one piece of a larger puzzle.
Biological credibility is available. Observation and mechanistic tests suggest a significant relationship between vitamin D and lower risk CRC. But clinical evidence is not yet forceful enough to recommend vitamin D as an independent strategy of preventing or treatment.
After saying, maintaining a sufficient level of vitamin D-at least 30 ng/ml-is a low, profitable measure of health. And in combination with other strategies, such as regular screening, vigorous diet, physical activity and personalized care, vitamin D can still play a valuable role in the general prevention of cancer.
Vitamin D is not a wonderful medicine – but it is part of a much broader picture. His role in colorectal cancer is promising, but he is still defined. Although it is not time to rely on the supplements themselves, providing an appropriate level of vitamin D – through exposure to the sun, diet or supplements – remains a wise choice for health.
Colorectal cancer is a intricate disease, and its solution requires an equally refined approach. For now, this means focusing on changes in the lifestyle based on evidence, regular research and maintaining information on the development of modern research.